The Efficacy of Omalizumab Treatment in Chronic Spontaneous Urticaria is Associated with Basophil Phenotypes

BACKGROUND: The mechanisms underlying disease pathogenesis in chronic spontaneous urticaria (CSU) and improvement with omalizumab are incompletely understood. OBJECTIVE: To examine if the rate of clinical remission is concordant with baseline basophil features or the rate of change of IgE-dependent...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Allergy Clin Immunol
Autors principals: Johal, Kirti J., Chichester, Kristin L., Oliver, Eric T., Devine, Kelly C., Bieneman, Anja P., Schroeder, John T., MacGlashan, Donald W., Saini, Sarbjit S.
Format: Artigo
Idioma:Inglês
Publicat: 2021
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8223444/
https://ncbi.nlm.nih.gov/pubmed/33713769
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaci.2021.02.038
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars